Tranexamic acid dosing study in heart surgery
Treatments studied
Part of Blood & lymphatic clinical trials.
This study compares different doses of tranexamic acid, a medicine that reduces bleeding, in patients having planned heart surgery with a heart-lung machine. It aims to find the best dose to prevent blood loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your heart surgery is scheduled in advance (not an emergency).
- Your surgery will use a heart-lung machine.
- You stopped taking blood thinners or anti-clotting medicines before surgery as your doctor instructed.
- You are 18 years or older.
- You are not pregnant.
- You do not have end-stage kidney disease or a history of epilepsy.
- You are not allergic to tranexamic acid.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether giving tranexamic acid (TXA) based on patient needs during heart surgery works better than a one-size-fits-all approach. It may help reduce bleeding during surgery, while monitoring for clotting-related side effects.
This study tests a quick bedside measurement of how well the drug tranexamic acid works to prevent bleeding during heart surgery. It may help doctors give the right dose to reduce blood loss.
This trial tests two medicines—ACT (a blood thinner) and tranexamic acid (a medicine to reduce bleeding)—to see which is better at controlling bleeding during heart surgery. It is for adults having planned heart surgery with a heart-lung machine.
This trial tests whether giving tranexamic acid through an IV during surgery can reduce bleeding in patients with high-risk conditions like obesity, heart problems, diabetes, or blood clotting issues. It may help make surgery safer for you.
This trial studies whether giving tranexamic acid (a medicine that helps reduce bleeding) during planned lower-back decompression surgery can lower blood loss or related complications. It compares patients who receive the infusion during surgery to those who meet study procedures and safety requirements.
This study compares two ways of giving a medicine called tranexamic acid — as a pill or through an IV — to see which works better at reducing bleeding during heart bypass surgery. If you are having heart surgery without a heart-lung machine, this trial may help you recover with less bleeding.
Hear when a new Blood Coagulation Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.